These studies suggest that subclonality has a limited role as a driver of mutant p53 heterogeneity in tumors, although they may underestimate heterogeneity as a consequence of limited size of the tumor sample and sequencing depth (McGranahan et al. 2015). The gene discussed is TP53; the disease is neoplasm.